格隆汇12月12日丨迈得医疗(688310.SH)公布，公司回购股份拟用于减少公司注册资本，回购股份金额 不低于人民币2,000万元（含），不超过人民币4,000万元（含），回购股份价格不超过人民币24元/股 （含）。 ...

迈得医疗公告，拟以2000万元-4000万元回购公司股份，回购价格不超过24元/股。 ...

证券之星消息，截至2025年12月9日收盘，迈得医疗(688310)报收于15.01元，下跌0.86%，换手率 1.39%，成交量2.31万手，成交额3489.02万元。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动性卖单产生的的成交额 是推动股价下跌的力量，这部分成交额被定义为资金流出。当天两者的差额即是当天两种力量相抵之后 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 注：主力资金为特大单成交，游资为大单成交，散户为中小单成交 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 12月9日的资金流向数据方面，主力资金净流入246.49万元，占总成交额7.06%，游资资金净流入22.84 万元，占总成交额0.65%，散户资金净流出269.33万元，占总成交额7.72%。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 迈得医疗2025年三季报显示，前三季度 ...

证券之星消息，截至2025年12月5日收盘，迈得医疗(688310)报收于15.21元，上涨2.08%，换手率 1.98%，成交量3.29万手，成交额4938.04万元。 12月5日的资金流向数据方面，主力资金净流入130.57万元，占总成交额2.64%，游资资金净流入209.15 万元，占总成交额4.24%，散户资金净流出339.72万元，占总成交额6.88%。 近5日资金流向一览见下表： 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 | 指标 | 迈得医疗 | 专用设备行业均值 | 行业排名 | | --- | --- | --- | --- | | 总市值 | 25.28亿元 | 76.97亿元 | 231 270 | | 净资产 | 8.4亿元 | 23.32亿元 | 204 270 | | 净利润 | 883.67万元 | 9886.83万元 | 190 270 | | 市盈率(动) | 214.58 | 129.31 | 176 270 | | 市净率 | 3.14 | 4.58 | 106 270 | | 毛利率 | 40.19% | 27.7 ...

证券之星消息，截至2025年12月4日收盘，迈得医疗(688310)报收于14.9元，下跌1.59%，换手率 1.75%，成交量2.9万手，成交额4332.04万元。 12月4日的资金流向数据方面，主力资金净流入689.35万元，占总成交额15.91%，游资资金净流出39.51 万元，占总成交额0.91%，散户资金净流出649.83万元，占总成交额15.0%。 近5日资金流向一览见下表： 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动性卖单产生的的成交额 是推动股价下跌的力量，这部分成交额被定义为资金流出。当天两者的差额即是当天两种力量相抵之后 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 注：主力资金为特大单成交，游资为大单成交，散户为中小单成交 | 指标 | 迈得医疗 | 专用设备行业均值 | 行业排名 | | --- | --- | --- | --- | | 总市值 | 24.77亿元 | 75.15亿元 | 232 270 | | 净 ...

| 代码 | 简称 | 今日涨跌 | 今日换手 | 5日均线 | 10日均线 | 5日较10日均线 | 最新价 | 较10日均线乖 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | （%） | 率（%） | （元） | （元） | 距离（%） | （元） | 离率（%） | | 688310 | 迈得 | -1.06 | 1.48 | 15.36 | 15.59 | -1.49 | 14.98 | -3.90 | | | 医疗 | | | | | | | | | 002759 | 天际 | -2.57 | 7.86 | 40.63 | 41.24 | -1.47 | 37.19 | -9.81 | | | 股份 | | | | | | | | | 600735 | ST新 华锦 | -1.61 | 2.52 | 5.83 | 5.91 | -1.29 | 5.51 | -6.71 | | 688189 | 南新 制药 | -5.59 | 3.56 | 9.21 | 9.30 | -1.01 | 8.79 | -5.48 | | 60 ...

Core Insights - The automation equipment sector experienced a decline of 1.46% on December 2, with Gokai Technology leading the drop [1][2] - The Shanghai Composite Index closed at 3897.71, down 0.42%, while the Shenzhen Component Index closed at 13056.7, down 0.68% [1] Stock Performance - Notable gainers in the automation equipment sector included: - Haixi Communications: Closed at 28.26, up 4.43% with a trading volume of 54,100 shares and a turnover of 152 million [1] - Ruisheng Intelligent: Closed at 82.60, up 2.99% with a trading volume of 17,400 shares and a turnover of 140 million [1] - Major decliners included: - Gokai Technology: Closed at 34.46, down 6.05% with a trading volume of 225,300 shares and a turnover of 784 million [2] - Tuosida: Closed at 28.69, down 4.05% with a trading volume of 130,900 shares and a turnover of 377 million [2] Capital Flow - The automation equipment sector saw a net outflow of 601 million from institutional investors, while retail investors contributed a net inflow of 118 million [2][3] - Key stocks with significant capital flow included: - Haixi Communications: Net inflow of 22.19 million from institutional investors, with a retail net inflow of 400,500 [3] - Ruisheng Intelligent: Net inflow of 15.12 million from institutional investors, but a net outflow of 14.41 million from retail investors [3]

Core Viewpoint - Midea Medical's stock has experienced fluctuations, with a year-to-date increase of 41.57% but a recent decline in the last 5, 20, and 60 trading days [1] Financial Performance - For the period from January to September 2025, Midea Medical achieved a revenue of 225 million yuan, representing a year-on-year growth of 2.31% [2] - The net profit attributable to the parent company was 8.84 million yuan, showing a year-on-year increase of 15.82% [2] Stock Market Activity - As of December 2, Midea Medical's stock price was 15.29 yuan per share, with a market capitalization of 2.54 billion yuan [1] - The stock has seen a net inflow of 353,400 yuan from main funds, with a significant portion of buying activity [1] - The company has appeared on the "Dragon and Tiger List" once this year, with the last occurrence on August 26, where it recorded a net buy of -57.70 million yuan [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 4,528, while the average circulating shares per person decreased by 15.97% to 36,709 shares [2] - The top ten circulating shareholders include notable funds, with some new entrants and exits among them [3] Dividend Distribution - Midea Medical has distributed a total of 202 million yuan in dividends since its A-share listing, with 99.30 million yuan distributed over the past three years [3] Business Overview - Midea Medical, established in March 2003 and listed in December 2019, specializes in the research, production, sales, and service of medical consumables and intelligent equipment [1] - The main revenue sources are safety infusion products (48.75%), blood purification products (26.27%), and other products (24.98%) [1]

Core Viewpoint - As of November 28, 2025, Maide Medical (688310) closed at 16.03 yuan, down 4.53%, with a turnover rate of 4.12% and a trading volume of 68,500 hands, resulting in a transaction amount of 110 million yuan [1] Financial Performance - For the first three quarters of 2025, the company's main revenue was 225 million yuan, an increase of 2.31% year-on-year; the net profit attributable to the parent company was 8.84 million yuan, up 15.82% year-on-year; the non-recurring net profit was -1.28 million yuan, a decrease of 526.58% year-on-year [5] - In Q3 2025, the company's single-quarter main revenue was 83.64 million yuan, an increase of 54.38% year-on-year; the single-quarter net profit attributable to the parent company was 2.79 million yuan, up 224.07% year-on-year; the single-quarter non-recurring net profit was 1.24 million yuan, an increase of 118.23% year-on-year [5] Market Position and Ratios - Maide Medical's total market value is 2.665 billion yuan, with a net asset of 840 million yuan and a net profit of 8.84 million yuan [3] - The company's price-to-earnings ratio (P/E) is 226.15, while the industry average is 130.51; the price-to-book ratio (P/B) is 3.31, compared to the industry average of 4.59 [3] - The gross profit margin is 40.19%, significantly higher than the industry average of 27.79%, while the net profit margin is -2.43%, lower than the industry average of 4.37% [3] Capital Flow - On November 28, 2025, the net inflow of main funds was 14.26 million yuan, accounting for 13.01% of the total transaction amount; the net inflow of retail funds was 1.73 million yuan, accounting for 15.83% of the total transaction amount [1] - In terms of margin trading, the financing buy amounted to 19.92 million yuan, with a net buy of 12.48 million yuan, while there were no securities sold or repaid [2]

Core Viewpoint - Midea Medical's stock price dropped by 5% to 15.95 CNY per share, with a total market capitalization of 2.651 billion CNY as of the report date [1] Company Overview - Midea Medical Industrial Equipment Co., Ltd. is located in Yuhuan City, Zhejiang Province, established on March 10, 2003, and listed on December 3, 2019 [1] - The company's main business involves the research, production, sales, and service of medical consumables and intelligent equipment [1] - Revenue composition: Safety infusion products account for 48.75%, blood purification products 26.27%, and other products 24.98% [1] Shareholder Information - Among the top ten circulating shareholders, one fund from Huaxia Fund holds shares in Midea Medical [2] - Huaxia Industry Prosperity Mixed A (003567) reduced its holdings by 1.0661 million shares in Q3, now holding 2.6036 million shares, representing 1.57% of circulating shares [2] - Estimated floating loss for Huaxia Industry Prosperity Mixed A today is approximately 2.187 million CNY [2] Fund Manager Details - The fund manager of Huaxia Industry Prosperity Mixed A is Zhong Shuai [3] - As of the report date, Zhong Shuai has a cumulative tenure of 5 years and 125 days, with total fund assets of 13.26 billion CNY [3] - Best fund return during tenure is 169.98%, while the worst return is -5.09% [3]